Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).
作者信息
Maschmeyer Georg, Bullinger Lars, Garcia-Vidal Carolina, Herbrecht Raoul, Maertens Johan, Menna Pierantonio, Pagano Livio, Thiebaut-Bertrand Anne, Calandra Thierry
机构信息
Certified Cancer Center, Klinikum Ernst von Bergmann, Charlottenstrasse 72, D-14467, Potsdam, Germany.
Department of Hematology, Oncology and Tumor Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.
出版信息
Leukemia. 2022 May;36(5):1450. doi: 10.1038/s41375-022-01570-9.
Abstract
摘要
相似文献
1
Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).更正：急性白血病中靶向药物和生物疗法的感染并发症。欧洲白血病感染会议（ECIL）制定的临床实践指南，欧洲白血病感染会议是欧洲血液与骨髓移植组（EBMT）、欧洲癌症研究与治疗组织（EORTC）、国际免疫受损宿主协会（ICHS）和欧洲白血病网（ELN）的合资机构。
Leukemia. 2022 May;36(5):1450. doi: 10.1038/s41375-022-01570-9.
2
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).急性白血病中靶向药物和生物疗法的感染并发症。欧洲白血病感染会议（ECIL）制定的临床实践指南，该会议由欧洲血液与骨髓移植组（EBMT）、欧洲癌症研究与治疗组织（EORTC）、国际免疫受损宿主协会（ICHS）和欧洲白血病网（ELN）联合举办。
Leukemia. 2022 May;36(5):1215-1226. doi: 10.1038/s41375-022-01556-7. Epub 2022 Apr 2.
3
European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.欧洲造血干细胞移植和白血病患者流感预防与管理指南：ECIL-4（2011年）总结，代表欧洲血液和骨髓移植协会（EBMT）、欧洲癌症研究与治疗组织（EORTC）、国际造血干细胞治疗学会（ICHS）和欧洲白血病网（ELN）联合成立的欧洲白血病感染会议（ECIL）发布
Transpl Infect Dis. 2013 Jun;15(3):219-32. doi: 10.1111/tid.12054. Epub 2013 Jan 31.
4
The First European Conference on Infections in Leukaemia - ECIL1: a current perspective.第一届欧洲白血病感染会议 - ECIL1：当前视角
Eur J Cancer. 2008 Oct;44(15):2112-7. doi: 10.1016/j.ejca.2008.07.008. Epub 2008 Aug 15.
5
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.欧洲白血病和造血干细胞移植受者抗真菌管理指南：ECIL 3-2009 更新概要。
Bone Marrow Transplant. 2011 May;46(5):709-18. doi: 10.1038/bmt.2010.175. Epub 2010 Jul 26.
6
European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011).欧洲白血病和干细胞移植中腺病毒感染的诊断与治疗指南：ECIL-4（2011年）总结
Transpl Infect Dis. 2012 Dec;14(6):555-63. doi: 10.1111/tid.12022. Epub 2012 Nov 12.
7
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus.第四届欧洲白血病感染会议（ECIL-4）：人类呼吸道合胞病毒、副流感病毒、偏肺病毒、鼻病毒和冠状病毒的诊断和治疗指南。
Clin Infect Dis. 2013 Jan;56(2):258-66. doi: 10.1093/cid/cis844. Epub 2012 Sep 28.
8
European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation.欧洲血液和骨髓移植学会风险评分可预测急性白血病患者接受单份脐带血移植的结局。
Biol Blood Marrow Transplant. 2017 Dec;23(12):2118-2126. doi: 10.1016/j.bbmt.2017.08.011. Epub 2017 Aug 12.
9
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.欧洲癌症研究与治疗组织（ECIL）关于白血病患者和造血干细胞移植受者侵袭性真菌病诊断中生物标志物使用的建议。
Bone Marrow Transplant. 2012 Jun;47(6):846-54. doi: 10.1038/bmt.2011.178. Epub 2011 Sep 19.
10
Celebrating 40 years of progress in bone marrow transplantation: a report from the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation.庆祝骨髓移植40年进展：欧洲血液与骨髓移植学会第40届年会报告
Future Microbiol. 2014;9(10):1117-21. doi: 10.2217/fmb.14.95.
引用本文的文献
1
COVID-19 in Adult Patients with Hematological Malignancies-Lessons Learned after Three Years of Pandemic.血液系统恶性肿瘤成年患者中的COVID-19——大流行三年后的经验教训
Biology (Basel). 2023 Apr 3;12(4):545. doi: 10.3390/biology12040545.
Zotero 插件